Hikma Pharmaceuticals PLC

HIK

Company Profile

  • Business description

    Hikma Pharmaceuticals PLC is engaged in developing, manufacturing, and marketing a broad range of generic, branded and non-branded, in-licensed pharmaceutical products. The firm operates in three segments: injectables, generics, and branded. The majority of the revenue for the company is generated from its injectables segment under which it supplies hospitals across markets with generic injectable products, supported by its manufacturing facilities. Geographically, North America is the company's key revenue generating market followed by Middle East and North Africa, United Kingdom, Europe and the rest of the world.

  • Contact

    1 New Burlington Place
    LondonW1S 2HR
    GBR

    T: +44 2073992760

    E: [email protected]

    https://www.hikma.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Drug Manufacturers - Specialty & Generic

    Fiscal Year End

    31 December 2025

    Employees

    2,150

Stocks News & Analysis

stocks

Best and worst performing ASX sectors of 2024

Exploring the ASX sectors that moved the market this year.
stocks

2 ASX companies with the traits of a long-term winner

Two companies that show promising signs of handsomely rewarding shareholders.
video

Our outlook for 2025

Morningstar Equity Market Strategist Lochlan Halloway discusses his view on what we can expect in markets in 2025. 

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,465.0044.500.53%
CAC 407,393.7613.020.18%
DAX 4020,024.66115.520.58%
Dow JONES (US)42,229.55314.67-0.74%
FTSE 1008,260.0987.071.07%
HKSE19,623.32436.63-2.18%
NASDAQ19,144.12166.67-0.86%
Nikkei 22539,894.54386.62-0.96%
NZX 50 Index13,110.74159.27-1.20%
S&P 5005,837.0844.55-0.76%
S&P/ASX 2008,201.2042.100.52%
SSE Composite Index3,262.5689.20-2.66%

Market Movers